Kintara Therapeutics Inc (NASDAQ: KTRA) Is Getting Increasingly Hard To Ignore
Currently, there are 39.04M common shares owned by the public and among those 38.16M shares have been available to trade. Insiders at the company have transacted a total of 1 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 1 of these insider trades were purchases, […]
Analysts Update Their Price Forecasts For Kintara Therapeutics Inc (KTRA)
Kintara Therapeutics Inc (KTRA) concluded trading on Wednesday at a closing price of $0.11, with 3.22 million shares of worth about $0.35 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -97.24% during that period and on Wednesday February 7 the price saw a […]
Following The Money: Institution’s Growing Stake In Kintara Therapeutics Inc (NASDAQ: KTRA)
Kintara Therapeutics Inc (KTRA) concluded trading on Wednesday at a closing price of $0.14, with 24.17 million shares of worth about $3.38 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -96.55% during that period and on Wednesday, January 31 the price saw a […]
Kintara Therapeutics Inc (KTRA): Insights At A Glance
After grabbing 22619.0 shares, the institutional investor is now in possession of 22619.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 0.67% having worth around $3845.0. Moreover, The Vanguard Group, Inc. increased its share by 12455.0 to have a control over 12455.0 shares. And Bank of America, NA […]
Kintara Therapeutics Inc (NASDAQ: KTRA) Stock In Prove Me State
After grabbing 22619.0 shares, the institutional investor is now in possession of 22619.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 0.67% having worth around $7645.0. Moreover, The Vanguard Group, Inc. increased its share by 12455.0 to have a control over 12455.0 shares. And Bank of America, NA […]
Kintara Therapeutics Inc (NASDAQ: KTRA) Loses -98.12% From High. Why That Could Change?
Nantahala Capital Management LLC recently announced the acquisition of new stake in Kintara Therapeutics Inc (NASDAQ:KTRA). This fresh investment now brings its stake to 0.67% valued currently at $7645.0. In addition, The Vanguard Group, Inc. raised its holdings by 12455.0 to 12455.0 shares. With over 122.43 million Kintara Therapeutics Inc (KTRA) shares trading Friday and […]
Investors Should Take Note Of Kintara Therapeutics Inc (KTRA)
After grabbing 22619.0 shares, the institutional investor is now in possession of 22619.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 0.67% having worth around $7645.0. Moreover, The Vanguard Group, Inc. increased its share by 12455.0 to have a control over 12455.0 shares. And Bank of America, NA […]
Kintara Therapeutics Inc (NASDAQ: KTRA): Do Not Miss The Gain Train
After grabbing 22619.0 shares, the institutional investor is now in possession of 22619.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 1.30% having worth around $84635.0. Moreover, The Vanguard Group, Inc. increased its share by 12455.0 to have a control over 12455.0 shares. And Bank of America, NA […]
Are Analysts Expecting A Better 2020 For Kintara Therapeutics Inc (KTRA)?
After grabbing 22619.0 shares, the institutional investor is now in possession of 22619.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 1.30% having worth around $84635.0. Moreover, The Vanguard Group, Inc. increased its share by 12455.0 to have a control over 12455.0 shares. And Bank of America, NA […]
Kintara Therapeutics Inc (KTRA): Insights At A Glance
Tower Research Capital LLC has recently announced that it has increased stake in Kintara Therapeutics Inc (NASDAQ:KTRA) by 166.72%. After grabbing 4777.0 shares, the institutional investor is now in possession of 2986.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 0.27% having worth around $19299.0. Moreover, JPMorgan Asset […]
